Loading...
Docoh

Comrit Investments 1

Filed: 4 May 22, 1:38pm

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Amendment No. 1
to

SCHEDULE TO

Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

 

 

 

CNL HEALTHCARE PROPERTIES, Inc.

(Name of Subject Company)

 

COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP

COMRIT INVESTMENTS LTD.

(Bidders)

 

COMMON STOCK, $0.01 PAR VALUE PER SHARE

(Title of Class of Securities)

 

None or unknown

(CUSIP Number of Class of Securities)

 

 

 

Ziv Sapir

Comrit Investments 1, Limited Partnership

9 Ahad Ha’am Street

Tel Aviv, Israel 6129101

+ 972-3-519-9936

 

Copy to:

 

Amos W. Barclay

Holland & Hart LLP

1800 Broadway, Suite 300

Boulder, Colorado 80302

Phone: (303) 473-2700

 

(Name, Address, and Telephone Number of

Person Authorized to Receive Notices and

Communications on Behalf of Offeror)

  
xCheck box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  
 Amount Previously Paid: $3,844.64
 Form or Registration Number: Schedule TO-T (File No. 005-90567)
 Filing Party: Comrit Investments 1, Limited Partnership; Comrit Investments Ltd.
 Date Filed: March 3, 2022
  
¨Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
  
 Check the appropriate boxes below to designate any transactions to which the statement relates:
  
xthird party tender offer subject to Rule 14d-1.
¨issuer tender offer subject to Rule 13e-4.
¨going private transaction subject to Rule 13e-3
¨amendment to Schedule 13D under Rule 13d-2
  
 Check the following box if the filing is a final amendment reporting the results of the tender offer: x
  
 If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
  
¨

Rule 13e-4(i) (Cross-Border Issuer Tender Offer)

 

¨

Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) 

 

 

 

 

 

 

FINAL AMENDMENT TO TENDER OFFER

 

This Final Amendment to the Tender Offer Statement on Schedule TO relates to the offer (the “Offer”) by Comrit Investments 1, Limited Partnership (the “Purchaser”) to purchase up to 8,900,000 shares of common stock, par value $0.01 per share (the “Shares”), in CNL Healthcare Properties, Inc., the subject company, at a purchase price of $4.66 per Share, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated March 3, 2022, and the related Assignment Form.

 

The Offer resulted in the tender by shareholders, and acceptance for payment by the Purchaser, of a total of approximately 575,710 Shares. Following the purchase of all of the tendered Shares, the Purchaser will own an aggregate of approximately 3,301,450 Shares, or approximately 1.9% of the total outstanding Shares.

 

 

 

 

SIGNATURES

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated:  May 4, 2022

 

Comrit Investments 1, LP

 

 By: Comrit Investments Ltd., its General Partner

 

 By:/s/ Ziv Sapir 
  

Ziv Sapir

Chief Executive Officer

 

 

Comrit Investments Ltd.

 

 By:/s/ Ziv Sapir 
  Ziv Sapir 
  Chief Executive Officer